Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Influence of high affinity haemoglobin on the response to normoxic and hypoxic exercise
Dominelli, Paolo B. , Wiggins, Chad C. , Baker, Sarah E. , Shepherd, John R. A. , Roberts, Shelly K., Roy, Tuhin K. , Curry, Timothy B. , Hoyer, James D., Oliveira, Jennifer L. , Herrick, Jennifer L. , Wiggins, Chad C , Roy, Tuhin K , Baker, Sarah E , Joyner, Michael J.

Mayo Clinic

The Journal of Physiology | January 10, 2020 | Volume: 598 | Issue: 8 | Pages: 1475-1490

10.1113/jp279161 | PMID 31923331 Get It

Key points Theoretical models suggest there is no benefit of high affinity haemoglobin to preserve maximal oxygen uptake in acute hypoxia but the comparative biology literature has many examples of species that are evolutionarily adapted to hypoxia and have high affinity haemoglobin. We studied humans with high affinity haemoglobin and compensatory polycythaemia. These subjects performed maximal exercise tests in normoxia and hypoxia to determine how their altered haemoglobin affinity impacts hypoxic exercise tolerance. The high affinity haemoglobin participants demonstrated an attenuated decline in maximal aerobic capacity in acute hypoxia. Those with high affinity haemoglobin had no worsening of pulmonary gas exchange during hypoxic exercise but had greater lactate and lower pH than controls for all exercise bouts. High affinity haemoglobin and compensatory polycythaemia mitigated the decline in exercise performance in acute hypoxia through a higher arterial oxygen content and an unchanged pulmonary gas exchange. AbstractThe longstanding dogma is that humans exhibit an acute reduction in haemoglobin (Hb) binding affinity for oxygen that facilitates adaptation to moderate hypoxia. However, many animals have adapted to high altitude through enhanced Hb binding affinity for oxygen. The objective of the study was to determine whether high affinity haemoglobin (HAH) affects maximal and submaximal exercise capacity. To accomplish this, we recruited individuals (n = 11, n = 8 females) with HAH (P50 = 16 ± 1 mmHg), had them perform normoxic and acute hypoxic (15% inspired oxygen) maximal exercise tests, and then compared their results to matched controls (P50 = 26 ± 1, n = 14, n = 8 females). Cardiorespiratory and arterial blood gases were collected throughout both exercise tests. Despite no difference in end‐exercise arterial oxygen tension in hypoxia (59 ± 6 vs. 59 ± 9 mmHg for controls and HAH, respectively), the HAH subjects’ oxyhaemoglobin saturation () was ∼7% higher. Those with HAH had an attenuated decline in maximal oxygen uptake () (4 ± 5% vs. 12 ± %, p < 0.001) in hypoxia and the change in between trials was related to the change in (r = −0.75, p < 0.0001). Compared to normoxia, the controls’ alveolar‐to‐arterial oxygen gradient significantly increased during hypoxic exercise, whereas pulmonary gas exchange in HAH subjects was unchanged between the two exercise trials. However, arterial lactate was significantly higher and arterial pH significantly lower in the HAH subjects for both exercise trials. We conclude that HAH attenuates the decline in maximal aerobic capacity and preserves pulmonary gas exchange during acute hypoxic exercise. Our data support the comparative biology literature indicating that HAH is a positive adaptation to acute hypoxia.
Motherhood and Anesthesiology: A Survey of the American Society of Anesthesiologists
Kraus, Molly B. , Dexter, Franklin , Patel, Perene V., Dodd, Sarah E. , Thomson, Holly M, Girardo, Marlene , Hertzberg, Linda B., Pearson, Amy C. S. , Pearson, Amy C S , Kraus, Molly B

Mayo Clinic

Anesthesia & Analgesia | January 10, 2020 | Volume: 130 | Issue: 5 | Pages: 1296-1302

10.1213/ane.0000000000004615 | PMID 31923001 Get It

BACKGROUND: The proportion of women medical school graduates in the United States has grown substantially; however, representation of women in anesthesiology lags behind. We sought to investigate factors associated with women recommending against a career in anesthesiology due to obstacles related to motherhood. METHODS: We surveyed 9525 women anesthesiologist members of the American Society of Anesthesiologists (ASA) with a web-based survey distributed via e-mail. Associations between whether women would counsel against anesthesiology due to obstacles related to motherhood and 34 related categorical variables were estimated. Fisher exact test was used for categorical binary variables, and Wilcoxon-Mann-Whitney test was used for ranked variables. RESULTS: The response rate for the primary question was 19.2%. Among the 1827 respondents to the primary question, 11.6% would counsel a female medical student against a career in anesthesiology due to obstacles pertaining to motherhood. Counseling against an anesthesiology career was not associated with ever being pregnant ( P = .16), or whether a woman was pregnant during residency or fellowship training ( P = .41) or during practice ( P = .16). No association was found between counseling against anesthesiology and training factors: total number of weeks of maternity leave ( P = .18), the percentage of women faculty ( P = .96) or residents ( P = .34), or the number of pregnant coresidents ( P = .66). Counseling against a career in anesthesiology was significantly associated with whether respondents’ desired age of childbearing/motherhood and desired number of children were adversely affected by work demands (with Bonferroni adjustment for the 34 comparisons, both P < .0001). The risk ratio of respondents whose desired childbearing age and desired number of children were affected by work demands counseling against a career in anesthesiology was 5.1 compared to women whose desired childbearing age and desired number of children were not affected (99% confidence interval [CI], 3.3–7.9; P < .0001; odds ratio, 6.2). CONCLUSIONS: In this study of 1827 women anesthesiologists, approximately 1 in 10 would counsel a student against a career in anesthesiology due to obstacles pertaining to motherhood, and this was associated with altering one’s timing and number of children due to job demands. Further research is needed to understand how women’s perception of a career in anesthesiology is related to factors influencing personal choices. Understanding women’s perceptions of motherhood in anesthesiology may help leaders support career longevity and personal satisfaction in this growing cohort of anesthesiologists.
Venous thromboembolism risk with contemporary lenalidomide‐based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta‐analysis
Chakraborty, Rajshekhar , Riaz, Irbaz Bin , Malik, Saad Ullah , Marneni, Naimisha , Garcia, Alex Mejia, Anwer, Faiz , Kumar, Shaji , Murad, M. Hassan , Majhail, Navneet S. , Bin Riaz, Irbaz, Kumar, Shaji K , Majhail, Navneet S , Murad, M Hassan , Chakraborty, Rajshekhar , Riaz, Irbaz B , Anwer, Faiz , Khorana, Alok A. , Rajkumar, S. Vincent , Wang, Zhen , Khan, Safi U.

Mayo Clinic

Cancer | January 8, 2020 | Volume: 126 | Issue: 8 | Pages: 1640-1650

10.1002/cncr.32682 | PMID 31913498 Get It

Background Thromboprophylaxis is routinely used with lenalidomide‐based regimens in multiple myeloma because of a substantial risk of venous thromboembolism (VTE). However, little is known about the incidence of VTE with contemporary lenalidomide‐based regimens. The objective of the current study was to estimate the incidence of VTE despite thromboprophylaxis with currently used lenalidomide‐based regimens in patients with myeloma. Methods The Ovid MEDLINE, Embase, and Cochrane databases were queried from study inception to January 2019 for keywords to cover the following concepts: “lenalidomide,” “venous thromboembolism,” and “multiple myeloma.” Phase 1, 2, and 3 clinical trials evaluating lenalidomide‐based regimens with thromboprophylaxis were included. The pooled incidence rate of VTE was estimated using a random‐effects model. Results The search generated 1372 citations, with 51 clinical trials and 9069 patients included for analysis. The most common thromboprophylaxis agents were aspirin, low‐molecular‐weight heparin or warfarin, administered either per risk‐stratification or at investigators' discretion. The pooled incidence of VTE in trials of patients who had newly diagnosed and relapsed/refractory myeloma was 6.2% (95% CI, 5.4%‐7.1%) over median treatment durations ranging from 2 to 34 cycles, which translated into 1.2 VTE events per 100 patient‐cycles (95% CI, 0.9‐1.7 VTE events per 100 patient‐cycles). Among contemporary regimens, the risk of VTE was low with combined lenalidomide and low‐dose dexamethasone (0.2 [95% CI, 0.1‐0.6] events/100 patient‐cycles) and lenalidomide maintenance (0.0 [95% CI, 0.0‐0.7] events per 100 patient‐cycles). VTE risk was higher with combined lenalidomide and low‐dose dexamethasone plus proteasome inhibitors (1.3 [95% CI, 0.7‐2.3] events per 100 patient‐cycles). Conclusions Despite adequate thromboprophylaxis, lenalidomide‐based regimens have a substantial risk of VTE in controlled clinical trial settings. Further studies are needed on new thromboprophylaxis strategies with regimens that have a high VTE risk.
Trends in utilization of sentinel node biopsy and adjuvant radiation in women ≥ 70
Gunn, Jinny , Lemini, Riccardo , Partain, Kristin N. , Yeager, Tamanie E. , Almerey, Tariq , McLaughlin, Sarah A., Gabriel, Emmanuel , Partain, Kristin, Yeager, Tamanie, Gabriel, Emmanuel M , Attwood, Kristopher M. , Bagaria, Sanjay P.

Mayo Clinic

The Breast Journal | January 7, 2020 | Volume: 26 | Issue: 7 | Pages: 1321-1329

10.1111/tbj.13750 | PMID 31908095 Get It

PSP-like syndrome after aortic surgery in adults (Mokri syndrome)
Tisel, Sarah M. , Ahlskog, J. Eric , Matsumoto, Joseph Y., Josephs, Keith A. , Duffy, Joseph R.

Mayo Clinic

Neurology Clinical Practice | January 6, 2020 | Volume: 10 | Issue: 3 | Pages: 245-254

10.1212/cpj.0000000000000708 | PMID 32642326 Get It

SPECC1L regulates palate development downstream of IRF6
Hall, Everett G. , Wenger, Luke W., Wilson, Nathan R. , Undurty-Akella, Sraavya S, Standley, Jennifer , Augustine-Akpan, Eno-Abasi, Kousa, Youssef A. , Acevedo, Diana S., Goering, Jeremy P., Pitstick, Lenore, Natsume, Nagato , Paroya, Shahnawaz, Busch, Tamara , Mori, Akihiro , Schultz‐Rogers, Laura , Klee, Eric W. , Babovic‐Vuksanovic, Dusica , Kroc, Sarah A., Eshete, Mekonen , Bjork, Bryan C. , Suzuki, Satoshi , Murray, Jeffrey C. , Schutte, Brian C. , Butali, Azeez , Saadi, Irfan , Schultz-Rogers, Laura E, Babovic-Vuksanovic, Dusica, Wilson, Nathan R, Augustine‐Akpan, Eno‐Abasi, Ito, Masaaki, Mori, Akihiro, Imura, Hideto , Adeyemo, Wasiu Lanre

Mayo Clinic

Human Molecular Genetics | January 6, 2020 | Volume: 29 | Issue: 5 | Pages: 845-858

10.1093/hmg/ddaa002 | PMID 31943082 Get It

Abstract SPECC1L mutations have been identified in patients with rare atypical orofacial clefts and with syndromic cleft lip and/or palate (CL/P). These mutations cluster in the second coiled-coil and calponin homology domains of SPECC1L and severely affect the ability of SPECC1L to associate with microtubules. We previously showed that gene-trap knockout of Specc1l in mouse results in early embryonic lethality. We now present a truncation mutant mouse allele, Specc1lΔC510, that results in perinatal lethality. Specc1lΔC510/ΔC510 homozygotes showed abnormal palate rugae but did not show cleft palate. However, when crossed with a gene-trap allele, Specc1lcGT/ΔC510 compound heterozygotes showed a palate elevation delay with incompletely penetrant cleft palate. Specc1lcGT/ΔC510 embryos exhibit transient oral epithelial adhesions at E13.5, which may delay shelf elevation. Consistent with oral adhesions, we show periderm layer abnormalities, including ectopic apical expression of adherens junction markers, similar to Irf6 hypomorphic mutants and Arhgap29 heterozygotes. Indeed, SPECC1L expression is drastically reduced in Irf6 mutant palatal shelves. Finally, we wanted to determine if SPECC1L deficiency also contributed to non-syndromic (ns) CL/P. We sequenced 62 Caucasian, 89 Filipino, 90 Ethiopian, 90 Nigerian and 95 Japanese patients with nsCL/P and identified three rare coding variants (p.Ala86Thr, p.Met91Iso and p.Arg546Gln) in six individuals. These variants reside outside of SPECC1L coiled-coil domains and result in milder functional defects than variants associated with syndromic clefting. Together, our data indicate that palate elevation is sensitive to deficiency of SPECC1L dosage and function and that SPECC1L cytoskeletal protein functions downstream of IRF6 in palatogenesis.
Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma
Zarei, Shabnam , Jenkins, Sarah M. , Voss, Jesse S. , Kerr, Sarah E. , Bell, Debra A., Wang, Yan

Mayo Clinic

American Journal of Surgical Pathology | December 24, 2019 | Volume: 44 | Issue: 3 | Pages: 316-328

10.1097/pas.0000000000001419 | PMID 31876585 Get It

Despite the current classification of high-grade serous carcinoma (HGSCA) and low-grade serous carcinoma (LGSCA) as mutually exclusive diseases based on morphology and molecular pathogenesis, cases with mixed morphologic features of HGSCA and LGSCA have been reported. Herein we assess the clinicopathologic, immunohistochemical (IHC), and molecular genetic characteristics of a group of these cases, which we termed indeterminate grade serous carcinoma (IGSCA) in comparison with groups of HGSCA and LGSCA. Using the World Health Organization (WHO) classification criteria, we selected 27 LGSCA and 19 IGSCA for detailed morphologic study. Thirteen classic HGSCA, 19 classic LGSCA, and 19 IGSCA were selected for p53 and BRAF V600E IHC and molecular genetic testing by next-generation sequencing. IGSCA showed the architectural patterns of invasion of LGSCA, but with higher grade nuclear features focally and a mitotic index intermediate between LGSCA and HGSCA. Few cases in the IGSCA group showed mutant TP53 by IHC or sequencing (4/18, 22.2%), 1 case had mutant BRAF non-V600E by sequencing, and 1 had an NRAS mutation. When present, the mutations were identical in the low-grade and high-grade areas. The IGSCA group had a long-term survival similar to the classic HGSCA group. IGSCA with mixed morphologic features of HGSCA and LGSCA is a rare and potentially clinically aggressive variant of serous carcinoma. Their distinct morphologic, but heterogenous molecular features, including low frequency of TP53 and BRAF mutations suggest that these rare tumors may have a different pathogenesis pathway compared with classic HGSCA and classic LGSCA.
Answer to January 2020 Photo Quiz
Jung, Sarah , Wengenack, Nancy L. , Wengenack, Nancy, Shi, Min , Schuetz, Audrey N.

Mayo Clinic

Journal of Clinical Microbiology | December 20, 2019 | Volume: 58 | Issue: 1 | Pages: No page available

10.1128/jcm.01612-18 | PMID 31871062 Get It

Photo Quiz: Rapidly Progressive Pneumonia in a Resident of the U.S. Midwest
Jung, Sarah , Wengenack, Nancy L. , Wengenack, Nancy, Shi, Min , Schuetz, Audrey N.

Mayo Clinic

Journal of Clinical Microbiology | December 20, 2019 | Volume: 58 | Issue: 1 | Pages: No page available

10.1128/jcm.01611-18 | PMID 31871061 Get It

1350: NEUROSCIENCE INTENSIVE CARE UNIT READMISSION RISK: ARE MEDICAL PREDICTION MODELS ACCURATE?
Peacock, Sarah , Grek, Ami , Rogers, Emily, White, Launia J. , Naessens, James M. , Freeman, William D.

Mayo Clinic

Critical Care Medicine | December 18, 2019 | Volume: 48 | Issue: 1 | Pages: 652-652

10.1097/01.ccm.0000645316.26854.71 Get It